Cargando…
Acute myocarditis after administration of BNT162b2 vaccine against COVID-19
Autores principales: | Cueva-Recalde, Juan F., Ibáñez-Muñoz, David, Meseguer-González, Daniel, Sola-Moreno, Teresa, Yanguas-Barea, Nerea, Ruiz-Arroyo, José R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Permanyer Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161815/ https://www.ncbi.nlm.nih.gov/pubmed/37037215 http://dx.doi.org/10.24875/ACM.21000270 |
Ejemplares similares
-
Acute Myocarditis Following the Administration of the Second BNT162b2 COVID-19 Vaccine Dose
por: Miqdad, Mohammed A, et al.
Publicado: (2021) -
Acute myopericarditis following administration of the BNT162b2 booster vaccine against COVID19
por: Sivan, S.K., et al.
Publicado: (2022) -
Acute myocarditis following administration of BNT162b2 vaccine
por: Habib, Mhd Baraa, et al.
Publicado: (2021) -
Myopericarditis After BNT162b2 mRNA Vaccination With Incidental Intramyocardial Bridging
por: Elghazal, Mohamed, et al.
Publicado: (2023) -
Acute myocarditis after administration of the BNT162b2 vaccine against COVID-19
por: Bautista García, Javier, et al.
Publicado: (2021)